Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
DOWNLOAD WHITEPAPER

Manufacturing of Cytotoxic and Non-Cytotoxic Drugs in a Multiproduct Facility

When different drug products are produced in shared facilities, the potential for cross-contamination is always a concern that needs to be addressed.

Drug products provide a benefit to the intended patient. However, as a cross-contaminant, they can pose a risk.

This is especially true when manufacturing oncology drugs, as many of them are highly potent substances with cytotoxic or genotoxic effects, while others are not.



Download to find out more.

Close
Close
Close

Go Top